Homozygous Thyroid Hormone Receptor β-Gene Mutations in Resistance to Thyroid Hormone: Three New Cases and Review of the Literature
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
CONTEXT: The most common cause of resistance to thyroid hormone (RTH) is heterozygous thyroid hormone receptor β (THRB) gene mutations. Homozygous mutations in the THRB gene are a rare event. OBJECTIVE: In this study, the clinical findings of three new patients (belonging to two families) homozygous for mutations in the THRB gene are compared to three other families in which affected individuals lack a normal TRβ. METHODS: We conducted clinical studies and genetic analyses. RESULTS: The clinical presentation in all three homozygous subjects was unusually severe; their phenotype was characterized by compromised intellectual development, tachycardia, goiter, growth retardation, and hearing loss. This was comparable with one other reported patient homozygous for mutant TRβ, but not in RTH due to THRB gene deletions. CONCLUSION: We report three new subjects, from two families, in whom RTH was associated with homozygous mutations in the THRB gene. They represent an important addition to the single known patient homozygous for a mutant TRβ. The clinical and laboratory abnormalities indicate a strong dominant-negative effect and are in agreement with data obtained from mice expressing a mutant Thrb in both alleles. This report strengthens the concept that the mutated TRβ interferes with the function of the TRα1 in humans.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In humans, hypothyroidism is associated with a poor prognosis in established heart failure (33) and TH can reduce intrahepatic triglyceride content (34,35).”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [34]
In the citing paper
“and TH can reduce intrahepatic triglyceride content [34, 35].”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [34]
Citations
Cites
The Syndromes of Resistance to Thyroid Hormone*
REFETOFF, S., WEISS, R. E., & USALA, S. J. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-3-348 · Cited by 873
Self-citationREFETOFF, S., DEWIND, L. T., & DEGROOT, L. J. (1967) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-27-2-279 · Cited by 568
Self-citationForrest, D., Hanebuth, E., Smeyne, R. J., Everds, N., Stewart, C. L., Wehner, J. M., & Curran, T. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00664.x · Cited by 440
Thyroid hormone receptor β is essential for development of auditory function
Forrest, D., Erway, L. C., Ng, L., Altschuler, R., & Curran, T. (1996) · Nature Genetics · doi:10.1038/ng0796-354 · Cited by 371
Refetoff, S., & Dumitrescu, A. M. (2007) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2007.03.005 · Cited by 295
Self-citationBrucker-Davis, F., Skarulis, M. C., Grace, M. B., Benichou, J., Hauser, P., Wiggs, E., & Weintraub, B. D. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-8-199510150-00002 · Cited by 275
Kaneshige, M., Kaneshige, K., Zhu, X.-G., Dace, A., Garrett, L., Carter, T. A., Kazlauskaite, R., Pankratz, D. G., Wynshaw-Boris, A., Refetoff, S., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.230285997 · Cited by 268
Self-citationCellular Action of Thyroid Hormone on the Heart
Dillmann, W. H. (2002) · Thyroid · doi:10.1089/105072502760143809 · Cited by 252
Parrilla, R., Mixson, A. J., McPherson, J. A., McClaskey, J. H., & Weintraub, B. D. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115542 · Cited by 244
An unliganded thyroid hormone receptor causes severe neurological dysfunction
Hashimoto, K., Curty, F. H., Borges, P. P., Lee, C. E., Abel, E. D., Elmquist, J. K., Cohen, R. N., & Wondisford, F. E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051454698 · Cited by 238
Cited by
Mechanisms of thyroid hormone action
Brent, G. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60047 · Cited by 1,244
Thyroid hormone receptors and resistance to thyroid hormone disorders
Ortiga-Carvalho, T. M., Sidhaye, A. R., & Wondisford, F. E. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.143 · Cited by 383
The syndromes of reduced sensitivity to thyroid hormone
Dumitrescu, A. M., & Refetoff, S. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.08.005 · Cited by 253
“Conversely, the severe signs of hypothyroidism in bone and brain of homozygotes with mut TRβs can be explained by the DNE of the double dose of the mut TRβs that interfere with TRα function as well [26].”
BackgroundSelf-citationThyroid hormone signaling in energy homeostasis and energy metabolism
McAninch, E. A., & Bianco, A. C. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12374 · Cited by 237
Thyroid hormone, thyroid hormone receptors, and cancer: a clinical perspective
Moeller, L. C., & Führer, D. (2013) · Endocrine-Related Cancer · doi:10.1530/erc-12-0219 · Cited by 184
“The clinical differences between patients with resistance to TH (RTH) due to TRb and TRa mutations further demonstrate that distinct physiological roles for the TR isoforms exist (Refetoff & Dumitrescu 2007, Bochukova et al. 2012, Ferrara et al. 2012, van Mullem et al. 2012).”
Background
Metadata
- Authors
- Ferrara, A. M., Onigata, K., Ercan, O., Woodhead, H., Weiss, R. E., & Refetoff, S.
- Affiliations
- University of Chicago (US)
- Istanbul University-Cerrahpaşa (TR)
- Sydney Children's Hospital (AU)
- Corresponding author
- Refetoff, Samuel
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2012-04
- Volume
- 97
- Issue
- 4
- Pages
- 1328-1336
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC3319181
- OpenAlex
- W2164383111
- Cited by
- 110
- References
- 33
- Citations by year
- 2026: 7 · 2025: 2 · 2024: 6 · 2023: 8 · 2022: 6 · 2021: 7 · 2020: 4 · 2019: 8 · 2018: 5 · 2017: 7 · 2016: 9 · 2015: 16 · 2014: 10 · 2013: 11 · 2012: 4
- FWCI
- 10.53
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R37-DK 15070, P60DK20595, R37DK015070, P60DK020595)
- National Center for Research Resources (5M01RR04999)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Keywords
- thyroid hormone resistance, thyroid hormone receptor beta, homozygous mutation, dominant negative effect, intellectual disability, tachycardia, goiter, growth retardation, hearing loss, thyroid hormone receptor alpha 1, familial case
- MeSH terms
- Child, Preschool, Female, Genes, Recessive, Homozygote, Humans, Infant, Newborn, Male, Mutation, Pedigree, Severity of Illness Index, Point Mutation, Thyroid Hormone Resistance Syndrome, Amino Acid Substitution, Thyroid Hormone Receptors beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Homozygous Thyroid Hormone Receptor β-Gene Mutations in Resistance to Thyroid Hormone: Three New Cases and Review of the Literature. https://app.cochat.ai/papers/10.1210/jc.2011-2642
- The paper
- Ferrara, A. M., Onigata, K., Ercan, O., Woodhead, H., Weiss, R. E., & Refetoff, S. (2012). Homozygous Thyroid Hormone Receptor β-Gene Mutations in Resistance to Thyroid Hormone: Three New Cases and Review of the Literature. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2011-2642
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.